Why the study?
Does selective site pacing using a transvenous 4-French catheter-delivered lead provide adequate pacing parameters and safety in patients requiring an implantable device?
Does selective site pacing using a transvenous 4-French catheter-delivered lead provide adequate pacing parameters and safety in patients requiring an implantable device?
The use of a 4-French catheter-delivered lead for selective site pacing is feasible and safe across various right atrial, right ventricular, and His-bundle locations.
No takes yet. Share an insight, caveat, or question.
Supports selective site pacing feasibility with 4Fr leads in practice; leaves open need for randomized efficacy trials versus conventional approaches.
Zanon et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: